CLEVELAND, Ohio — The benefits of getting regular exercise, combining two cancer drugs with chemotherapy, and using AI to ...

Pall Mall Medical teamed up with Blaze Run Club for this year's 'Poo Protest,' encouraging early detection of bowel cancer ...

Nearly 10,000 cases of advanced bowel cancer are diagnosed in England each year, with cases in young adults rising. There are limited options for treating advanced bowel cancer. Scientists have now ...

Biomarkers are redefining how oncology trials are designed, shifting from single-mutation targeting to comprehensive genomic ...

Scientists at The Institute of Cancer Research have developed a method to identify bowel cancer patients most likely to ...

The platform trial will add new arms testing Enhertu in solid tumors with HER2 amplification and gather data on Tafinlar-Mekinist's tissue-agnostic benefit for regular approval.

Two BRAF-targeted agents already used together in several solid tumors have won parallel regulatory support in Europe. In its March 2026 meeting, the European Medicines Agency’s Committee for ...

Designation granted by FDA recognizes the potential of plixorafenib, a novel, investigational paradox breaker and BRAF inhibitor, to provide substantial improvement over available therapies First ...

A national industrial electrical contractor is now owned by the Baton Rouge Area Foundation, bringing a $1 billion asset to the foundation and strengthening both groups' ability to contribute to ...

BACKGROUND: Genetic variants in components or regulators of the RAS-MAPK signaling pathway are causative for severe and early-onset hypertrophic cardiomyopathy (HCM) in patients with Noonan syndrome ...

A new review from the Icahn School of Medicine at Mount Sinai and the Hospital Clínic de Barcelona provides one of the ...